Category: Parkinson's Disease
Global Parkinson's Disease
-
The 2025-2030 World Outlook for Anti-Parkinson's Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Parkinson's Disease Deep Brain Stimulation Devices
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Parkinson's Disease Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Neurological Biomarkers for Alzheimers and Parkinsons Diseases
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Deep Brain Stimulation Devices for Parkinson's Diseases
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
Deep Brain Stimulation Market Report by Stimulation Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Application (Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2024-2032
... Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2024-2032 The global deep brain stimulation market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group ... Read More
-
Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Parkinson's Disease Treatments is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Brain Monitoring Market Size Study & Forecast, by Product Type (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Functional Magnetic Resonance Imaging, Other Product Types), by Application (Parkinson's Disease, Traumatic Brain Injury, Epilepsy, Other Applications), by End User (Hospitals, Diagnostic Centers), and Regional Analysis, 2023-2030
... (Hospitals, Diagnostic Centers), and Regional Analysis, 2023-2030 Global Brain Monitoring Market is valued at approximately USD 6.01 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.35% during ... Read More
-
Immunoassay for Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics, Research), By Region and Competition
... By Region and Competition Global Immunoassay for Neurological Biomarkers Market was valued at USD 624.22 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 17.22% through ... Read More
-
Brain Monitoring Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Device (EEG, EMG, MEG, ICP, MRI, fMRI, CT), By End-User (Hospitals, Neurology Centers, Clinics & ASC), By Application (Traumatic brain injury (TBI), Stroke, Dementia, Headache disorders, Sleep disorders, Parkinson disease, Epilepsy, Huntington disease, Other diseases), By Region, and By Competition
... injury (TBI), Stroke, Dementia, Headache disorders, Sleep disorders, Parkinson disease, Epilepsy, Huntington disease, Other diseases), By Region, and By Competition Global Brain Monitoring Market was valued at USD 3.46 billion in 2023 and will see ... Read More
-
Global Parkinson's Disease Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 6.63 billion by 2029, growing at a CAGR of 3.58% during the forecast period (2024-2029). The Covid-19 pandemic has impacted the market significantly. The COVID-19 pandemic had few major effects on the ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer's Disease, Parkinson's Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... Pacific, Latin America, Middle East and Africa). Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate ... Read More
-
Global Parkinson's Disease Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Parkinson's Disease Therapeutics is forecast to a readjusted size of US$ 3605.2 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential ... Read More
-
Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Global Forecast to 2028
... at an estimated USD 6.2 billion in 2023 and is projected to reach USD 11.0 billion by 2028, at a CAGR of 12.0% during the forecast period. Market growth is driven by factors such as ... Read More
-
Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Global Forecast 2024-2030
... 3.15 billion in 2023 and expected to reach USD 3.49 billion in 2024, at a CAGR 10.88% to reach USD 6.51 billion by 2030. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market FPNV Positioning Matrix The FPNV ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Global Parkinson's Disease (PD) Drugs Market Research Report 2024(Status and Outlook)
... turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The Global Parkinson's Disease (PD) Drugs Market Size was estimated at USD 5775.68 ... Read More
-
Treatment Syndromes Dementia Movement Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) Leading Pharmaceutical Companies Aim to Address Rising Incidence of Cognitive Defects The global market for the treatment of syndromes related to dementia and movement disorders has witnessed remarkable growth in recent years, as ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... global neurological biomarkers market size is expected to reach USD 18.75 billion by 2030, expanding at a CAGR of 12.89% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increased ... Read More
-
Neurosurgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 21.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. Neurosurgery devices refer to various tools and instruments that are used for conducting surgeries and treating various pathologies in the ... Read More
-
Neurostimulation: Technologies and Global Markets
... devices (invasive and noninvasive) and their current and historical market revenues. Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, ... Read More
-
2023 Global Forecast for Parkinson'S Disease Treatment Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2023 Global Forecast for Parkinson'S Disease (Pd) Drugs Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
... Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030 Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
Research Assistance
